We are pleased to announce that we now accept all major credit cards, as well as HSA and FSA for payment!
Perimenopause is the transition leading up to menopause, when ovarian hormone production becomes less predictable and menstrual cycles begin to change.
This stage can bring hot flashes, night sweats, difficulty sleeping, mood changes, brain fog, vaginal dryness, low libido, fatigue, and other symptoms that affect daily comfort and quality of life.
Perimenopause hormone treatment may help some women manage disruptive symptoms, but hormones are not the only option and are not appropriate for everyone.
Optimal Female Wellness provides individualized evaluation to help patients understand what may be changing, consider other possible causes of symptoms, and explore hormonal or nonhormonal treatment based on medical history, priorities, and personal goals.
Menopause refers to one specific point in time: 12 months after the final menstrual period.
The years leading up to that point are known as the menopause transition or perimenopause.
The National Institute on Aging notes that the transition commonly begins between ages 45 and 55 and may continue for several years. Symptoms related to menopause may last approximately 2 to 8 years, although the pattern varies significantly between women.
Perimenopause may therefore include months or years of:
There is no single timeline that applies to everyone.
Changes in menstruation are often one of the first signs of perimenopause.
Periods may become:
ACOG notes that during perimenopause, some months may include ovulation while others do not. This can change both cycle length and bleeding patterns.
Hormone levels also fluctuate rather than simply declining in a smooth, predictable line.
That is one reason symptoms may feel inconsistent. A woman may experience several weeks of hot flashes and then have a period when they temporarily improve.
Perimenopause can affect several aspects of health.
Possible symptoms include:
Not every woman experiences all of these symptoms.
Some notice only changes in their menstrual cycle, while others have symptoms that significantly interfere with sleep, work, relationships, or intimacy.
Many women report changes in concentration and memory during the menopause transition.
These may include:
The Menopause Society notes that brain fog during perimenopause is common and that cognitive changes are usually mild and remain within normal limits.
Poor sleep, stress, anxiety, depression, thyroid disease, medication effects, and anemia may also affect concentration.
Worsening or unusual cognitive changes should therefore be evaluated independently rather than automatically attributed to hormones.
Lower and fluctuating estrogen may affect vaginal and vulvar tissues before menopause is complete.
Symptoms can include:
Some women also experience urinary symptoms.
Sexual desire may decline indirectly when intimacy becomes uncomfortable or when poor sleep and fatigue reduce interest.
Treatment may include lubricants, vaginal moisturizers, local hormone treatment, pelvic-floor care, or another approach depending on the symptoms.
Mood symptoms can change during perimenopause.
Women may notice:
Hormone fluctuations may contribute, but sleep disruption, stress, medications, and previous mental-health conditions may also play a role.
A history of depression, anxiety, significant PMS, or postpartum mood symptoms may be relevant when evaluating new emotional changes during midlife.
Persistent depression, severe anxiety, or symptoms affecting daily function require appropriate mental-health evaluation rather than being dismissed as “just hormones.”
Hormone therapy can relieve certain symptoms of perimenopause and menopause.
ACOG identifies hormone therapy as an option for symptoms such as:
Treatment may involve systemic estrogen, with a progestogen when needed.
Local vaginal treatment may be used when vaginal dryness or discomfort is the primary concern.
Women who still have a uterus generally need a progestogen when systemic estrogen is prescribed.
Estrogen can stimulate the uterine lining.
Adding a progestogen helps protect against excessive endometrial growth and the increased risk associated with unopposed systemic estrogen.
Treatment may be structured as:
The exact approach depends on the patient’s stage of transition, bleeding pattern, symptoms, and medical history.
No.
A clinician should review medical history before prescribing systemic hormone therapy.
ACOG notes that systemic hormone therapy is generally not recommended for women with certain histories, including:
Unexplained vaginal bleeding also requires evaluation.
The type, dose, route, and treatment duration should be individualized rather than applying one hormone plan to every patient.
Menopause is confirmed after 12 consecutive months without a menstrual period or spotting when there is no other explanation.
At that point, a woman is considered postmenopausal rather than perimenopausal.
Some symptoms may continue after the final period.
Hot flashes, vaginal dryness, sleep changes, and other menopause symptoms do not necessarily end immediately.
Treatment can continue to be adjusted based on symptoms and health needs.
Heavy menstrual bleeding may contribute to iron deficiency and anemia.
Possible symptoms include:
When low energy develops alongside increasingly heavy perimenopausal periods, blood-count or iron testing may be appropriate.
Treating fatigue with hormones alone would not correct iron deficiency if ongoing blood loss is the actual cause.
Symptoms and menstrual patterns can change quickly during perimenopause.
A treatment that works well one year may need adjustment later.
Follow-up may include reviewing:
Hormone therapy should not be managed solely by repeatedly increasing doses in response to fluctuating laboratory values.
Symptoms, clinical response, safety, and treatment goals matter.
Perimenopause can feel unpredictable because menstrual cycles, sleep, temperature regulation, mood, and sexual health may all change at the same time.
Optimal Female Wellness provides individualized evaluation and treatment support for women navigating the menopause transition.
Schedule an appointment to discuss your menstrual changes, hot flashes, sleep, mood, vaginal symptoms, medications, pregnancy-prevention needs, and whether perimenopause hormone treatment, nonhormonal medication, nutritional support, or another approach may be appropriate.
Perimenopause is the transition leading up to menopause when ovarian hormone production and menstrual cycles become less predictable. Menopause is confirmed after 12 months without a menstrual period.
The timeline varies considerably. The menopause transition may continue for several years, and menopause-related symptoms may last approximately two to eight years or longer in some women.
Possible signs include irregular periods, hot flashes, night sweats, sleep disruption, mood changes, brain fog, vaginal dryness, low libido, and fatigue.
Hormone therapy may be worth discussing when symptoms such as hot flashes, night sweats, or vaginal concerns interfere with sleep, comfort, or quality of life and the patient is an appropriate candidate.
Not always. Age, symptoms, and menstrual history are often more informative because hormone levels can fluctuate substantially during the transition.
Yes. Ovulation can still occur even when periods are irregular. Standard menopause hormone therapy is not contraception.
It can change bleeding patterns, but the effect depends on the treatment used. Combined hormonal contraception may provide more predictable bleeding for some women who also need pregnancy prevention.
Hormone therapy may improve sleep when hot flashes or night sweats are repeatedly causing awakenings. Chronic insomnia, sleep apnea, anxiety, and other sleep disorders may need separate treatment.
Yes. Depending on the symptom, options may include nonhormonal prescription medication, vaginal moisturizers or lubricants, sleep treatment, mental-health care, and other supportive strategies.
Bleeding between periods, bleeding after sex, very heavy bleeding, bleeding that lasts substantially longer than usual, or any bleeding after menopause should be medically evaluated.